GGrantIndex
← Leaderboards

Guojun Bu

Washington University

$30,610,787
Attributed
$38,424,274
Total exposure
24
Grants
16
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $9.5M · FY200521
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$45,244,566 · 25

By mechanism

RF1$13,962,827 · 2
R01$13,368,607 · 9
U19$8,480,155 · 4
P01$4,445,276 · 5
R37$2,426,864 · 1
P50$1,599,526 · 2

Top collaborators

Most similar at Washington University

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposS DiseaseBrainApolipoprotein EAmyloidMolecularMetabolismPathway InteractionsNeuronsPathogenesisLow Density Lipoprotein ReceptorMediatingMouse ModelProtein IsoformsIn VivoAgingProteinsLdl-Receptor Related Protein 1PathologyAffectEventS Disease RiskAmyloid Beta-ProteinReceptor

Grant awards (97)

Biology and pathobiology of apoE in aging and Alzheimer's disease$6,820,292
U19 · FY2021 · AG · contact PI
TREM2-mediated microglial dynamic function in Alzheimer disease$742,112
R01 · FY2021 · AG · contact PI
Human iPSC Models Core$706,238
U19 · FY2021 · AG · contact PI
Impact of vascular apoE in aging and AD$547,750
U19 · FY2021 · AG · contact PI
Administrative Core$405,875
U19 · FY2021 · AG · contact PI
Biomarker Core$286,007
P30 · FY2021 · AG · contact PI
TREM2-mediated microglial dynamic function in Alzheimer disease$756,237
R01 · FY2020 · AG · contact PI
ApoE pathway in cerebrovascular Aβ clearance in Alzheimer's disease$606,716
R37 · FY2020 · AG · contact PI
Biomarker Core$286,007
P30 · FY2020 · AG · contact PI
ApoE pathway in cerebrovascular Aβ clearance in Alzheimer’s disease$606,716
R37 · FY2019 · AG · contact PI
ApoE and LRP1 in brain insulin signaling and glucose metabolism (Competitive Renewal)$320,825
R01 · FY2019 · AG · contact PI
Biomarker Core$286,007
P30 · FY2019 · AG · contact PI
Integrative translational discovery of vascular risk factors in aging and dementia$249,412
RF1 · FY2019 · AG
Integrative translational discovery of vascular risk factors in aging and dementia$163,895
RF1 · FY2019 · AG
ApoE pathway in cerebrovascular Aβ clearance in Alzheimer’s disease$606,716
R37 · FY2018 · AG · contact PI
ApoE and LRP1 in brain insulin signaling and glucose metabolism (Competitive Renewal)$320,825
R01 · FY2018 · AG · contact PI
Project 3$235,243
P50 · FY2018 · AG · contact PI
Molecular pathobiology of soluble TREM2 in Alzheimer's disease.$4,147,115
RF1 · FY2017 · AG
Integrative translational discovery of vascular risk factors in aging and dementia$3,577,700
RF1 · FY2017 · AG
ApoE pathway in cerebrovascular Aβ clearance in Alzheimer’s disease$606,716
R37 · FY2017 · AG · contact PI
ApoE isoform-specific therapy for Alzheimer disease$320,825
R01 · FY2017 · AG · contact PI
ApoE and LRP1 in brain insulin signaling and glucose metabolism (Competitive Renewal)$320,825
R01 · FY2017 · AG · contact PI
Project 3$242,519
P50 · FY2017 · AG · contact PI
Integrative translational discovery of vascular risk factors in aging and dementia$497,395
RF1 · FY2016 · AG
ApoE isoform-specific therapy for Alzheimer disease$320,825
R01 · FY2016 · AG · contact PI
ApoE receptor pathways and abeta metabolism$320,825
R01 · FY2016 · AG · contact PI
ApoE and LRP1 in brain insulin signaling and glucose metabolism (Competitive Renewal)$320,825
R01 · FY2016 · AG · contact PI
Lipoprotein Receptor And Synaptic Regulation Of A^ Metabolism$236,512
P01 · FY2016 · NS · contact PI
Project 3$200,320
P50 · FY2016 · AG · contact PI
Integrative translational discovery of vascular risk factors in aging and dementia$5,327,310
RF1 · FY2015 · AG
ApoE and LRP1 in brain insulin signaling and glucose metabolism (Competitive Renewal)$320,825
R01 · FY2015 · AG · contact PI
ApoE isoform-specific therapy for Alzheimer disease$311,200
R01 · FY2015 · AG · contact PI
ApoE receptor pathways and abeta metabolism$311,200
R01 · FY2015 · AG · contact PI
Lipoprotein Receptor And Synaptic Regulation Of A^ Metabolism$240,293
P01 · FY2015 · NS · contact PI
Project 3$192,442
P50 · FY2015 · AG · contact PI
ApoE receptor pathways and abeta metabolism$320,825
R01 · FY2014 · AG · contact PI
ApoE isoform-specific therapy for Alzheimer disease$320,825
R01 · FY2014 · AG · contact PI
BRAIN LIPID METABOLISM, DENDRITES AND SYNAPSES IN AGING AND ALZHEIMER'S DISEASE$305,421
R01 · FY2014 · AG · contact PI
Lipoprotein Receptor And Synaptic Regulation Of A^ Metabolism$293,199
P01 · FY2014 · NS · contact PI
Project 3$200,320
P50 · FY2014 · AG · contact PI
ApoE isoform-specific therapy for Alzheimer disease$320,825
R01 · FY2013 · AG · contact PI
ApoE receptor pathways and abeta metabolism$303,180
R01 · FY2013 · AG · contact PI
Lipoprotein Receptor And Synaptic Regulation Of A^ Metabolism$292,126
P01 · FY2013 · NS · contact PI
BRAIN LIPID METABOLISM, DENDRITES AND SYNAPSES IN AGING AND ALZHEIMER'S DISEASE$288,622
R01 · FY2013 · AG · contact PI
MOLECULAR AND CELL BIOLOGY CORE (MCB CORE)$234,278
P01 · FY2013 · AG · contact PI
LRP AND APP PROCESSING IN NEURODEGENERATON$202,887
P01 · FY2013 · AG · contact PI
ApoE receptor pathways and abeta metabolism$320,825
R01 · FY2012 · AG · contact PI
BRAIN LIPID METABOLISM, DENDRITES AND SYNAPSES IN AGING AND ALZHEIMER'S DISEASE$305,421
R01 · FY2012 · AG · contact PI
Lipoprotein Receptor And Synaptic Regulation Of A^ Metabolism$263,985
P01 · FY2012 · NS · contact PI
MOLECULAR AND CELL BIOLOGY CORE (MCB CORE)$247,919
P01 · FY2012 · AG · contact PI
LRP AND APP PROCESSING IN NEURODEGENERATON$216,079
P01 · FY2012 · AG · contact PI
BRAIN LIPID METABOLISM, DENDRITES AND SYNAPSES IN AGING AND ALZHEIMER'S DISEASE$305,421
R01 · FY2011 · AG · contact PI
MOLECULAR AND CELL BIOLOGY CORE (MCB CORE)$256,182
P01 · FY2011 · AG · contact PI
LRP AND APP PROCESSING IN NEURODEGENERATON$224,705
P01 · FY2011 · AG · contact PI
BRAIN LIPID METABOLISM, DENDRITES AND SYNAPSES IN AGING AND ALZHEIMER'S DISEASE$311,600
R01 · FY2010 · AG · contact PI
ApoE Receptor Pathways to Intraneuronal Abeta$259,920
R01 · FY2010 · AG · contact PI
MOLECULAR AND CELL BIOLOGY CORE (MCB CORE)$258,453
P01 · FY2010 · AG · contact PI
LRP AND APP PROCESSING IN NEURODEGENERATON$228,443
P01 · FY2010 · AG · contact PI
ApoE Receptor Pathways to Intraneuronal Abeta$33,627
R01 · FY2010 · AG · contact PI
MOLECULAR AND CELL BIOLOGY CORE (MCB CORE)$315,541
P01 · FY2009 · AG · contact PI
ApoE Receptor Pathways to Intraneuronal Abeta$296,512
R01 · FY2009 · AG · contact PI
LRP AND APP PROCESSING IN NEURODEGENERATON$232,370
P01 · FY2009 · AG · contact PI
LRP AND APP PROCESSING IN NEURODEGENERATION$85,959
R01 · FY2009 · AG · contact PI
LRP AND APP PROCESSING IN NEURODEGENERATION$311,600
R01 · FY2008 · AG · contact PI
ApoE Receptor Pathways to Intraneuronal Abeta$296,512
R01 · FY2008 · AG · contact PI
Molecular Pathobiology of LRP1B Tumor Suppressor$267,657
R01 · FY2008 · CA · contact PI
ApoE Receptor Pathways to Intraneuronal Abeta$23,484
R01 · FY2008 · AG · contact PI
ApoE Receptor Pathways to Intraneuronal Abeta$302,729
R01 · FY2007 · AG · contact PI
Molecular Pathobiology of LRP1B Tumor Suppressor$267,657
R01 · FY2007 · CA · contact PI
ApoE Receptor Pathways to Intraneuronal Abeta$312,796
R01 · FY2006 · AG · contact PI
Molecular Pathobiology of LRP1B Tumor Suppressor$275,651
R01 · FY2006 · CA · contact PI
Trafficking of LRP and Megalin in Polarized Cells$32,010
R03 · FY2006 · TW · contact PI
Molecular Pathobiology of LRP1B Tumor Suppressor$282,285
R01 · FY2005 · CA
Trafficking of LRP and Megalin in Polarized Cells$32,780
R03 · FY2005 · TW
BIOGENESIS OF LIPOPROTEINS RECEPTORS$282,801
R01 · FY2004 · DK
Molecular Pathobiology of LRP1B Tumor Suppressor$282,285
R01 · FY2004 · CA
Trafficking of LRP and Megalin in Polarized Cells$38,500
R03 · FY2004 · TW
BIOGENESIS OF LIPOPROTEINS RECEPTORS$275,682
R01 · FY2003 · DK
RAP AS A MOLECULAR CHAPERONE/ESCORT PROTEIN FOR LRP$303,177
R01 · FY2002 · HL
BIOGENESIS OF LIPOPROTEINS RECEPTORS$268,884
R01 · FY2002 · DK
Role of LRP &its ligand tPA in LTP &aging$0
P50 · FY2002 · AG
Role of LRP &its ligand tPA in LTP &aging$0
P50 · FY2002 · AG
Role of LRP &its ligand tPA in LTP &aging$0
P50 · FY2002 · AG
RAP AS A MOLECULAR CHAPERONE/ESCORT PROTEIN FOR LRP$291,679
R01 · FY2001 · HL
Role of LRP &its ligand tPA in LTP &aging$264,341
P50 · FY2001 · AG
NEUROTROPHIN REGULATION OF LRP IN CNS NEURONS$228,546
R01 · FY2001 · NS
CORE--MORPHOLOGY RESOURCE$175,576
P01 · FY2001 · DK
BIOGENESIS OF LIPOPROTEIN RECEPTORS$175,576
P01 · FY2001 · DK
BIOGENESIS OF LIPOPROTEINS RECEPTORS$125,438
R01 · FY2001 · DK
Role of LRP &its ligand tPA in LTP &aging$0
P50 · FY2001 · AG
Role of LRP &its ligand tPA in LTP &aging$0
P50 · FY2001 · AG
Role of LRP &its ligand tPA in LTP &aging$0
P50 · FY2001 · AG
RAP AS A MOLECULAR CHAPERONE/ESCORT PROTEIN FOR LRP$279,722
R01 · FY2000 · HL
Role of LRP &its ligand tPA in LTP &aging$264,341
P50 · FY2000 · AG
NEUROTROPHIN REGULATION OF LRP IN CNS NEURONS$223,690
R01 · FY2000 · NS
CORE--MORPHOLOGY RESOURCE$175,576
P01 · FY2000 · DK
BIOGENESIS OF LIPOPROTEIN RECEPTORS$175,576
P01 · FY2000 · DK